Please login to the form below

Not currently logged in
Email:
Password:

Webinar: AMNOG – One Year On

IMS Consulting Group and Booz & Co will discuss the changes to Germany’s pharma pricing system in the latest PMLiVE webinar on Monday 23 April

Germany Rhine

Once the first country in Europe to get innovative products, thanks to its favourable pricing structure, Germany used to be a popular launch destination for the pharmaceutical industry.

In December AstraZeneca's antiplatelet drug Brilique (ticagrelor) become the first drug to be backed under the country's new pricing assessment laws, but the introduction of AMNOG and the G-BA test has left many in pharma wondering if they would not be better off avoiding the country altogether.

On Monday 23 April at 12:30pm (UK time) PMLiVE's latest webinar, AMNOG - One Year, will feature speakers from IMS Consulting Group and Booz & Co discussing these important pricing changes and what they mean for pharma. To registor for the free webinar use the box below or click this link.

 

The webinar can be viewed on this page on Monday and then shortly after it finishes it will be available here in an archived form.

• PMLiVE's country report series also has more on the German healthcare market

20th April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...